United Kingdom

Product news

Product News
Press release: NICE recommends first anti-CGRP migraine therapy: AJOVY®(fremanezumab)
12/03/2020
Read more
New treatment for Scottish migraine sufferers

13/01/2020

Read more
Teva in Migraine & Headache: Science Leaders, Community Supporters

13/01/2020

Read more
Teva Presents Positive Results from Phase IIIb FOCUS study of Fremanezumab in Adults with Migraine
02/07/2019
Read more
Teva Ref: NW403